title: TLR3 agonists and proinflammatory antitumor activities.
authors.forename: Sherven
authors.initials: S
authors.lastname: Sharma
authors.forename: Li
authors.initials: L
authors.lastname: Zhu
authors.forename: Michael
authors.initials: M
authors.lastname: Davoodi
authors.forename: Marni
authors.initials: M
authors.lastname: Harris-White
authors.forename: Jay M
authors.initials: JM
authors.lastname: Lee
authors.forename: Maie
authors.initials: M
authors.lastname: St John
authors.forename: Ravi
authors.initials: R
authors.lastname: Salgia
authors.forename: Steven
authors.initials: S
authors.lastname: Dubinett
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D019496:Cancer Vaccines; D006801:Humans; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D051196:Toll-Like Receptor 3 / Q000819:agonists* / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; D051196:Toll-Like Receptor 3